Abstract
The authors report an exceedingly rare complication of rheumatoid arthritis, i.e. acquired hemophilia due to anti-factor VIII autoantibody production. Treatment with intravenous immune globulin ensured control of hemorrhagic manifestations by inducing a transient rise in factor VIII level.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Arthritis, Rheumatoid / complications*
-
Arthritis, Rheumatoid / immunology
-
Autoantibodies / isolation & purification
-
Factor VIII / immunology
-
Female
-
Hemophilia A / etiology*
-
Hemophilia A / immunology
-
Hemophilia A / therapy
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use*
Substances
-
Autoantibodies
-
Immunoglobulins, Intravenous
-
Factor VIII